The role of the myofibroblast in tumor stroma remodeling

Cell Adhesion and Migration

Volumn 6, Issue 3, 2012, Pages 203-219

  Otranto, Marcela ^a,b   Sarrazy, Vincent ^c   Bonté, Frédéric ^d   Hinz, Boris ^c   Gabbiani, Giulio ^e   Desmoulière, Alexis ^a  

^a UNIVERSITY OF LIMOGES   (France)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSITY OF TORONTO   (Canada)

^d Parfums Christian Dior   (France)

^e UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Extracellular matrix; Fibrosis; Mechanosensing; Transforming growth factor beta; Wound healing

Indexed keywords

COLLAGEN; ELASTIN; FIBROBLAST GROWTH FACTOR; FIBRONECTIN; GLYCOPROTEIN; HYALURONIC ACID; PLASMIN; VASCULOTROPIN;

BASEMENT MEMBRANE; BIOCHEMISTRY; BIOPHYSICS; CANCER GROWTH; CELL ACTIVITY; CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL JUNCTION; CELL MIGRATION; EPITHELIUM CELL; FIBROBLAST; HUMAN; LIVER CARCINOMA; MESENCHYMAL STEM CELL; MYOFIBROBLAST; NONHUMAN; PATHOLOGY; PROTEIN EXPRESSION; REVIEW; STROMA CELL; TISSUE REPAIR; TUMOR CELL; TUMOR GROWTH; WILD TYPE; WOUND HEALING;

EID: 84864962631     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/cam.20377     Document Type: Review

References (282)

1. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002; 3:349-63; PMID:11988769; http://dx.doi.org/10.1038/nrm809
2. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315:1650-9; PMID:3537791
3. Schäfer M, Werner S. Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol 2008; 9:628-38; PMID:18628784; http://dx.doi.org/10.1038/nrm2455
4. Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci 2010; 123:4195-200; PMID:21123617; http://dx.doi.org/10.1242/jcs.023820
5. Fata JE, Werb Z, Bissell MJ. Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes. Breast Cancer Res 2004; 6:1-11; PMID:14680479
6. Schultz GS, Wysocki A. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen 2009; 17:153-62; PMID: 19320882; http://dx.doi.org/10.1111/j.1524-475X.2009.00466.x
7. Mott JD, Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 2004; 16:558-64; PMID:15363807; http://dx.doi.org/10.1016/j.ceb.2004.07.010
8. Hynes RO. The extracellular matrix: not just pretty fibrils. Science 2009; 326:1216-9; PMID:19965464; http://dx.doi.org/10.1126/science.1176009
9. Sweetwyne MT, Murphy-Ullrich JE. Thrombospondin1 in tissue repair and fibrosis: TGF-β-dependent and independent mechanisms. Matrix Biol 2012; 31:178-86; PMID:22266026; http://dx.doi.org/10.1016/j.matbio.2012.01.006
10. Todorovic V, Rifkin DB. LTBPs, more than just an escort service. J Cell Biochem 2012; 113:410-8; PMID:22223425; http://dx.doi.org/10.1002/jcb.23385
11. Ramirez F, Rifkin DB. Extracellular microfibrils: contextual platforms for TGFbeta and BMP signaling. Curr Opin Cell Biol 2009; 21:616-22; PMID:19525102; http://dx.doi.org/10.1016/j.ceb.2009.05.005
12. Robinson KL, Marasco SF, Street AM. Practical management of anticoagulation, bleeding and blood product support for cardiac surgery. Part one: bleeding and anticoagulation issues. Heart Lung Circ 2001; 10:142-53; PMID:16352053; http://dx.doi.org/10.1046/j.1444-2892.2001.00096.x
13. Le Varlet B, Chaudagne C, Saunois A, Barré P, Sauvage C, Berthouloux B, et al. Age-related functional and structural changes in human dermo-epidermal junction components. J Investig Dermatol Symp Proc 1998; 3:172-9; PMID:9734834
14. Dumas M, Chaudagne C, Bonté F, Meybeck A. In vitro biosynthesis of type I and III collagens by human dermal fibroblasts from donors of increasing age. Mech Ageing Dev 1994; 73:179-87; PMID:8057688; http://dx.doi.org/10.1016/ 0047-6374(94)90050-7
15. Quan T, Qin Z, Xia W, Shao Y, Voorhees JJ, Fisher GJ. Matrix-degrading metalloproteinases in photoaging. J Investig Dermatol Symp Proc 2009; 14:20-4; PMID:19675548; http://dx.doi.org/10.1038/jidsymp.2009.8
16. Fisher GJ, Varani J, Voorhees JJ. Looking older: fibroblast collapse and therapeutic implications. Arch Dermatol 2008; 144:666-72; PMID:18490597; http://dx.doi.org/10.1001/archderm.144.5.666
17. Cox TR, Erler JT. Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis Model Mech 2011; 4:165-78; PMID:21324931; http://dx.doi.org/10.1242/dmm.004077
18. Jackson KA, Majka SM, Wulf GG, Goodell MA. Stem cells: a minireview. J Cell Biochem Suppl 2002; 38:1-6; PMID:12046843; http://dx.doi.org/10.1002/jcb. 10045
19. Kolonin MG, Evans KW, Mani SA, Gomer RH. Alternative origins of stroma in normal organs and disease. Stem Cell Res 2012; 8:312-23; PMID:22209011; http://dx.doi.org/10.1016/j.scr.2011.11.005
20. Salem HK, Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 2010; 28:585-96; PMID:19967788
21. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006; 119:2204-13; PMID:16684817; http://dx.doi.org/10.1242/jcs.02932
22. Hunt GC, Schwarzbauer JE. Tightening the connections between cadherins and fibronectin matrix. Dev Cell 2009; 16:327-8; PMID:19289079; http://dx.doi.org/10.1016/j.devcel.2009.02.013
23. Jahoda CA, Whitehouse J, Reynolds AJ, Hole N. Hair follicle dermal cells differentiate into adipogenic and osteogenic lineages. Exp Dermatol 2003; 12:849-59; PMID:14714566; http://dx.doi.org/10.1111/j.0906-6705.2003.00161.x
24. Festa E, Fretz J, Berry R, Schmidt B, Rodeheffer M, Horowitz M, et al. Adipocyte lineage cells contribute to the skin stem cell niche to drive hair cycling. Cell 2011; 146:761-71; PMID:21884937; http://dx.doi.org/10.1016/j.cell. 2011.07.019
25. Hunt DP, Jahoda C, Chandran S. Multipotent skin-derived precursors: from biology to clinical translation. Curr Opin Biotechnol 2009; 20:522-30; PMID:19896826; http://dx.doi.org/10.1016/j.copbio.2009.10.004
26. Toma JG, Akhavan M, Fernandes KJ, Barnabé-Heider F, Sadikot A, Kaplan DR, et al. Isolation of multi-potent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 2001; 3:778-84; PMID:11533656; http://dx.doi.org/10.1038/ncb0901-778
27. Fernandes KJ, Toma JG, Miller FD. Multipotent skin-derived precursors: adult neural crest-related precursors with therapeutic potential. Philos Trans R Soc Lond B Biol Sci 2008; 363:185-98; PMID:17282990; http://dx.doi.org/10.1098/ rstb.2006.2020
28. Yamanishi H, Fujiwara S, Soma T. Perivascular localization of dermal stem cells in human scalp. Exp Dermatol 2012; 21:78-80; PMID:22151396; http://dx.doi.org/10.1111/j.1600-0625.2011.01407.x
29. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008; 3:301-13; PMID:18786417; http://dx.doi.org/10.1016/j.stem.2008. 07.003
30. Paquet-Fifield S, Schlüter H, Li A, Aitken T, Gangatirkar P, Blashki D, et al. A role for pericytes as microenvironmental regulators of human skin tissue regeneration. J Clin Invest 2009; 119:2795-806; PMID:19652362
31. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119:1420-8; PMID:19487818; http://dx.doi.org/10.1172/ JCI39104
32. Shook D, Keller R. Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development. Mech Dev 2003; 120:1351-83; PMID:14623443; http://dx.doi.org/10.1016/j.mod.2003.06.005
33. Yang L, Moses HL. Transforming growth factor beta: tumor suppressor or promoter? Are host immune cells the answer? Cancer Res 2008; 68:9107-11; PMID:19010878; http://dx.doi.org/10.1158/0008-5472.CAN-08-2556
34. Zeisberg EM, Potenta S, Xie L, Zeisberg M, Kalluri R. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res 2007; 67:10123-8; PMID:17974953; http://dx.doi.org/10. 1158/0008-5472.CAN-07-3127
35. Potenta S, Zeisberg E, Kalluri R. The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer 2008; 99:1375-9; PMID:18797460; http://dx.doi.org/10.1038/sj.bjc.6604662
36. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112:1776-84; PMID:14679171
37. Roufosse CA, Direkze NC, Otto WR, Wright NA. Circulating mesenchymal stem cells. Int J Biochem Cell Biol 2004; 36:585-97; PMID:15010325; http://dx.doi.org/10.1016/j.biocel.2003.10.007
38. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. Circulating fibrocytes define a new leukocyte sub-population that mediates tissue repair. Mol Med 1994; 1:71-81; PMID:8790603
39. Mattoli S, Bellini A, Schmidt M. The role of a human hematopoietic mesenchymal progenitor in wound healing and fibrotic diseases and implications for therapy. Curr Stem Cell Res Ther 2009; 4:266-80; PMID:19500063; http://dx.doi.org/10.2174/157488809789649232
40. Bianchetti L, Barczyk M, Cardoso J, Schmidt M, Bellini A, Mattoli S. Extracellular matrix remodelling properties of human fibrocytes. J Cell Mol Med 2012; 16:483-95; PMID:21595824; http://dx.doi.org/10.1111/j.1582-4934.2011. 01344.x
41. Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991; 78:55-62; PMID:2070060
42. Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med (Maywood) 2001; 226:507-20; PMID:11395921
43. Pittenger MF. Mesenchymal stem cells from adult bone marrow. Methods Mol Biol 2008; 449:27-44; PMID:18370081; http://dx.doi.org/10.1007/978-1-60327-169- 1-2
44. He Q, Wan C, Li G. Concise review: multipotent mesenchymal stromal cells in blood. Stem Cells 2007; 25:69-77; PMID:16973831; http://dx.doi.org/10.1634/ stemcells.2006-0335
45. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284:143-7; PMID:10102814; http://dx.doi.org/10.1126/science.284.5411.143
46. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8:315-7; PMID:16923606; http://dx.doi.org/10.1080/14653240600855905
47. Crossno JT, Jr., Majka SM, Grazia T, Gill RG, Klemm DJ. Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells. J Clin Invest 2006; 116:3220-8; PMID:17143331; http://dx.doi.org/10.1172/JCI28510
48. Werner S, Krieg T, Smola H. Keratinocyte-fibroblast interactions in wound healing. J Invest Dermatol 2007; 127:998-1008; PMID:17435785; http://dx.doi.org/10.1038/sj.jid.5700786
49. Sarrazy V, Billet F, Micallef L, Coulomb B, Desmoulière A. Mechanisms of pathological scarring: role of myofibroblasts and current developments. Wound Repair Regen 2011; 19(Suppl 1):s10-5; PMID:21793960; http://dx.doi.org/10.1111/j.1524-475X.2011.00708.x
50. Schauer IG, Rowley DR. The functional role of reactive stroma in benign prostatic hyperplasia. Differentiation 2011; 82:200-10; PMID:21664759; http://dx.doi.org/10.1016/j.diff.2011.05.007
51. Hayward SW, Rosen MA, Cunha GR. Stromalepithelial interactions in the normal and neoplastic prostate. Br J Urol 1997; 79(Suppl 2):18-26; PMID:9126066
52. Risbridger GP, Taylor RA. Minireview: regulation of prostatic stem cells by stromal niche in health and disease. Endocrinology 2008; 149:4303-6; PMID:18535102; http://dx.doi.org/10.1210/en.2008-0465
53. Cunha GR, Cooke PS, Kurita T. Role of stromal-epithelial interactions in hormonal responses. Arch Histol Cytol 2004; 67:417-34; PMID:15781983; http://dx.doi.org/10.1679/aohc.67.417
54. Risbridger G, Wang H, Young P, Kurita T, Wang YZ, Lubahn D, et al. Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium. Dev Biol 2001; 229:432-42; PMID:11150243; http://dx.doi.org/10.1006/dbio.2000.9994
55. Silberstein GB, Strickland P, Coleman S, Daniel CW. Epithelium-dependent extracellular matrix synthesis in transforming growth factor-beta 1-growth-inhibited mouse mammary gland. J Cell Biol 1990; 110:2209-19; PMID:2351697; http://dx.doi.org/10.1083/jcb.110.6.2209
56. Heine U, Munoz EF, Flanders KC, Ellingsworth LR, Lam HY, Thompson NL, et al. Role of transforming growth factor-beta in the development of the mouse embryo. J Cell Biol 1987; 105:2861-76; PMID:3320058; http://dx.doi.org/10.1083/ jcb.105.6.2861
57. Ferguson JE, Schor AM, Howell A, Ferguson MW. Changes in the extracellular matrix of the normal human breast during the menstrual cycle. Cell Tissue Res 1992; 268:167-77; PMID:1499048; http://dx.doi.org/10.1007/BF00338066
58. Blaustein M, Pelisch F, Coso OA, Bissell MJ, Kornblihtt AR, Srebrow A. Mammary epithelial-mesenchymal interaction regulates fibronectin alternative splicing via phosphatidylinositol 3-kinase. J Biol Chem 2004; 279:21029-37; PMID:15028734; http://dx.doi.org/10.1074/jbc.M314260200
59. Singh P, Carraher C, Schwarzbauer JE. Assembly of fibronectin extracellular matrix. Annu Rev Cell Dev Biol 2010; 26:397-419; PMID:20690820; http://dx.doi.org/10.1146/annurev-cellbio-100109-104020
60. Jolicoeur F, Gaboury LA, Oligny LL. Basal cells of second trimester fetal breasts: immunohistochemical study of myoepithelial precursors. Pediatr Dev Pathol 2003; 6:398-413; PMID:14708733; http://dx.doi.org/10.1007/s10024-003- 1125-y
61. Coulomb B, Lebreton C, Dubertret L. Influence of human dermal fibroblasts on epidermalization. J Invest Dermatol 1989; 92:122-5; PMID:2909624; http://dx.doi.org/10.1111/1523-1747.ep13071335
62. Velnar T, Bailey T, Smrkolj V. The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res 2009; 37:1528-42; PMID:19930861
63. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature 2008; 453:314-21; PMID:18480812; http://dx.doi.org/10.1038/ nature07039
64. Campos AC, Groth AK, Branco AB. Assessment and nutritional aspects of wound healing. Curr Opin Clin Nutr Metab Care 2008; 11:281-8; PMID:18403925; http://dx.doi.org/10.1097/MCO.0b013e3282fbd35a
65. Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 2011; 20:576-90; PMID:22094253; http://dx.doi.org/10. 1016/j.ccr.2011.09.009
66. Siljander PR. Platelet-derived microparticles - an updated perspective. Thromb Res 2011; 127(Suppl 2): S30-3; PMID:21193112; http://dx.doi.org/10.1016/ S0049-3848(10)70152-3
67. Webber J, Steadman R, Mason MD, Tabi Z, Clayton A. Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res 2010; 70:9621-30; PMID:21098712; http://dx.doi.org/10.1158/0008-5472.CAN-10-1722
68. Dvorak HF, Weaver VM, Tlsty TD, Bergers G. Tumor microenvironment and progression. J Surg Oncol 2011; 103:468-74; PMID:21480238; http://dx.doi.org/10. 1002/jso.21709
69. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420:860-7; PMID:12490959; http://dx.doi.org/10.1038/nature01322
70. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003; 83:835-70; PMID:12843410
71. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen 2008; 16:585-601; PMID:19128254; http://dx.doi.org/10.1111/j.1524-475X.2008.00410.x
72. Ruffell B, Au A, Rugo HS, Esserman LJ, Hwang ES, Coussens LM. Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A 2012; 109:2796-801; PMID:21825174; http://dx.doi.org/10.1073/pnas.1104303108
73. Tan TT, Coussens LM. Humoral immunity, inflammation and cancer. Curr Opin Immunol 2007; 19:209-16; PMID:17276050; http://dx.doi.org/10.1016/j.coi.2007. 01.001
74. Shaw TJ, Martin P. Wound repair at a glance. J Cell Sci 2009; 122:3209-13; PMID:19726630; http://dx.doi.org/10.1242/jcs.031187
75. Desmoulière A, Redard M, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995; 146:56-66; PMID:7856739
76. Darby IA, Bisucci T, Pittet B, Garbin S, Gabbiani G, Desmoulière A. Skin flap-induced regression of granulation tissue correlates with reduced growth factor and increased metalloproteinase expression. J Pathol 2002; 197:117-27; PMID:12081196; http://dx.doi.org/10.1002/path.1074
77. Kwan P, Hori K, Ding J, Tredget EE. Scar and contracture: biological principles. Hand Clin 2009; 25:511-28; PMID:19801124; http://dx.doi.org/10.1016/ j.hcl.2009.06.007
78. Ehrlich HP, Desmoulière A, Diegelmann RF, Cohen IK, Compton CC, Garner WL, et al. Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 1994; 145:105-13; PMID:8030742
79. Buchanan EP, Longaker MT, Lorenz HP. Fetal skin wound healing. Adv Clin Chem 2009; 48:137-61; PMID:19803418; http://dx.doi.org/10.1016/S0065-2423(09) 48006-5
80. Estes JM, Vande Berg JS, Adzick NS, MacGillivray TE, Desmoulière A, Gabbiani G. Phenotypic and functional features of myofibroblasts in sheep fetal wounds. Differentiation 1994; 56:173-81; PMID:8034132; http://dx.doi.org/10.1046/j.1432-0436.1994.5630173.x
81. Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res 2010; 89:219-29; PMID:20139336; http://dx.doi.org/10.1177/0022034509359125
82. Gabbiani G, Ryan GB, Majne G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 1971; 27:549-50; PMID:5132594; http://dx.doi.org/10.1007/BF02147594
83. Hinz B. The myofibroblast: paradigm for a mechanically active cell. J Biomech 2010; 43:146-55; PMID:19800625; http://dx.doi.org/10.1016/j.jbiomech. 2009.09.020
84. Hinz B, Mastrangelo D, Iselin CE, Chaponnier C, Gabbiani G. Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am J Pathol 2001; 159:1009-20; PMID:11549593; http://dx.doi.org/10.1016/S0002-9440(10)61776-2
85. Hinz B, Celetta G, Tomasek JJ, Gabbiani G, Chaponnier C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 2001; 12:2730-41; PMID:11553712
86. Orimo A, Weinberg RA. Heterogeneity of stromal fibroblasts in tumors. Cancer Biol Ther 2007; 6:618-9; PMID:18027438; http://dx.doi.org/10.4161/cbt.6. 4.4255
87. Sugimoto H, Mundel TM, Kieran MW, Kalluri R. Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther 2006; 5:1640-6; PMID:17106243; http://dx.doi.org/10.4161/cbt.5.12.3354
88. Arnoldi R, Chaponnier C, Gabbiani G, Hinz B. Heterogeneity of smooth muscle. In: Hill J, ed. Muscle: Fundamental Biology and Mechanisms of Disease: Elsevier Inc, 2012.
89. Armulik A, Genové G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 2011; 21:193-215; PMID:21839917; http://dx.doi.org/10.1016/j.devcel.2011.07.001
90. Dore-Duffy P, Cleary K. Morphology and properties of pericytes. Methods Mol Biol 2011; 686:49-68; PMID:21082366; http://dx.doi.org/10.1007/978-1-60761- 938-3-2
91. Hinz B, Phan SH, Thannickal VJ, Prunotto M, Desmoulière A, Varga J, et al. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol 2012; 180:1340-55; PMID:22387320; http://dx.doi.org/10.1016/j.ajpath.2012.02.004
92. Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 2007; 127:526-37; PMID:17299435; http://dx.doi.org/10.1038/ sj.jid.5700613
93. Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol 2010; 7:425-36; PMID:20585339; http://dx.doi.org/10.1038/ nrgastro.2010.97
94. Dranoff JA, Wells RG. Portal fibroblasts: Under-appreciated mediators of biliary fibrosis. Hepatology 2010; 51:1438-44; PMID:20209607; http://dx.doi.org/10.1002/hep.23405
95. Desmoulière A. Hepatic stellate cells: the only cells involved in liver fibrogenesis? A dogma challenged. Gastroenterology 2007; 132:2059-62; PMID:17484899; http://dx.doi.org/10.1053/j.gastro.2007.03.075
96. Hardie WD, Glasser SW, Hagood JS. Emerging concepts in the pathogenesis of lung fibrosis. Am J Pathol 2009; 175:3-16; PMID:19497999; http://dx.doi.org/10.2353/ajpath.2009.081170
97. Araya J, Nishimura SL. Fibrogenic reactions in lung disease. Annu Rev Pathol 2010; 5:77-98; PMID:20078216; http://dx.doi.org/10.1146/annurev.pathol.4. 110807.092217
98. Hoyles RK, Derrett-Smith EC, Khan K, Shiwen X, Howat SL, Wells AU, et al. An essential role for resident fibroblasts in experimental lung fibrosis is defined by lineage-specific deletion of high-affinity type II transforming growth factor β receptor. Am J Respir Crit Care Med 2011; 183:249-61; PMID:20709822; http://dx.doi.org/10.1164/rccm.201002-0279OC
99. van den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, Narula J. Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol 2010; 7:30-7; PMID:19949426; http://dx.doi.org/10.1038/nrcardio.2009.199
100. Leask A. Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res 2010; 106:1675-80; PMID:20538689; http://dx.doi.org/10.1161/CIRCRESAHA.110. 217737
101. Porter KE, Turner NA. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther 2009; 123:255-78; PMID:19460403; http://dx.doi.org/ 10.1016/j.pharmthera.2009.05.002
102. Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 2011; 7:684-96; PMID:22009250; http://dx.doi.org/10.1038/nrneph.2011.149
103. De Wever O, Demetter P, Mareel M, Bracke M. Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer 2008; 123:2229-38; PMID:18777559; http://dx.doi.org/10.1002/ijc.23925
104. Anderberg C, Pietras K. On the origin of cancer-associated fibroblasts. Cell Cycle 2009; 8:1461-2; PMID:19395855; http://dx.doi.org/10.4161/cc.8.10.8557
105. Cirri P, Chiarugi P. Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Cancer Metastasis Rev 2012; 31:195-208; PMID:22101652; http://dx.doi.org/10.1007/s10555-011-9340-x
106. Guyot C, Lepreux S, Darby IA, Desmoulière A. The biology of tumor stroma. The cancer handbook, 2nd edn 2007; 1:155-67.
107. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006; 6:392-401; PMID:16572188; http://dx.doi.org/10.1038/nrc1877
108. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2:442-54; PMID:12189386; http://dx.doi.org/10.1038/nrc822
109. Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 2008; 19:2282-7; PMID:18987304; http://dx.doi.org/10.1681/ASN.2008050513
110. Kizu A, Medici D, Kalluri R. Endothelial-mesenchymal transition as a novel mechanism for generating myofibroblasts during diabetic nephropathy. Am J Pathol 2009; 175:1371-3; PMID:19729485; http://dx.doi.org/10.2353/ajpath.2009. 090698
111. Chapman HA. Epithelial-mesenchymal interactions in pulmonary fibrosis. Annu Rev Physiol 2011; 73:413-35; PMID:21054168; http://dx.doi.org/10.1146/ annurev-physiol-012110-142225
112. Piera-Velazquez S, Li Z, Jimenez SA. Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol 2011; 179:1074-80; PMID:21763673; http://dx.doi.org/10.1016/j.ajpath.2011.06.001
113. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, et al. Endothelial-tomesenchymal transition contributes to cardiac fibrosis. Nat Med 2007; 13:952-61; PMID:17660828; http://dx.doi.org/10.1038/nm1613
114. Zeisberg M, Yang C, Martino M, Duncan MB, Rieder F, Tanjore H, et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 2007; 282:23337-47; PMID:17562716; http://dx.doi.org/10.1074/jbc.M700194200
115. Pinzani M. Epithelial-mesenchymal transition in chronic liver disease: fibrogenesis or escape from death? J Hepatol 2011; 55:459-65; PMID:21320559; http://dx.doi.org/10.1016/j.jhep.2011.02.001
116. Coen M, Gabbiani G, Bochaton-Piallat ML. Myofibroblast-mediated adventitial remodeling: an underestimated player in arterial pathology. Arterioscler Thromb Vasc Biol 2011; 31:2391-6; PMID:21868702; http://dx.doi.org/10.1161/ATVBAHA.111.231548
117. Kidd S, Spaeth E, Watson K, Burks J, Lu H, Klopp A, et al. Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma. PLoS One 2012; 7:e30563; PMID:22363446; http://dx.doi.org/10.1371/journal.pone.0030563
118. Ishii G, Sangai T, Sugiyama K, Ito T, Hasebe T, Endoh Y, et al. In vivo characterization of bone marrowderived fibroblasts recruited into fibrotic lesions. Stem Cells 2005; 23:699-706; PMID:15849177; http://dx.doi.org/10.1634/ stemcells.2004-0183
119. Direkze NC, Hodivala-Dilke K, Jeffery R, Hunt T, Poulsom R, Oukrif D, et al. Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res 2004; 64:8492-5; PMID:15574751; http://dx.doi.org/10.1158/0008-5472. CAN-04-1708
120. Forbes SJ, Russo FP, Rey V, Burra P, Rugge M, Wright NA, et al. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 2004; 126:955-63; PMID:15057733; http://dx.doi.org/10.1053/j.gastro.2004.02.025
121. Schmidt M, Sun G, Stacey MA, Mori L, Mattoli S. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 2003; 171:380-9; PMID:12817021
122. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004; 114:438-46; PMID:15286810
123. Sakai N, Wada T, Yokoyama H, Lipp M, Ueha S, Matsushima K, et al. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci U S A 2006; 103:14098-103; PMID:16966615; http://dx.doi.org/10.1073/pnas.0511200103
124. Kisseleva T, Uchinami H, Feirt N, Quintana- Bustamante O, Segovia JC, Schwabe RF, et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 2006; 45:429-38; PMID:16846660; http://dx.doi.org/10. 1016/j.jhep.2006.04.014
125. Haudek SB, Xia Y, Huebener P, Lee JM, Carlson S, Crawford JR, et al. Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc Natl Acad Sci U S A 2006; 103:18284-9; PMID:17114286; http://dx.doi.org/10. 1073/pnas.0608799103
126. Andersson-Sjöland A, de Alba CG, Nihlberg K, Becerril C, Ramírez R, Pardo A, et al. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol 2008; 40:2129-40; PMID:18374622; http://dx.doi.org/10.1016/j.biocel.2008.02.012
127. Wada T, Sakai N, Matsushima K, Kaneko S. Fibrocytes: a new insight into kidney fibrosis. Kidney Int 2007; 72:269-73; PMID:17495856; http://dx.doi.org/ 10.1038/sj.ki.5002325
128. Moeller A, Gilpin SE, Ask K, Cox G, Cook D, Gauldie J, et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009; 179:588-94; PMID:19151190; http://dx.doi.org/ 10.1164/rccm.200810-1534OC
129. Mori L, Bellini A, Stacey MA, Schmidt M, Mattoli S. Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res 2005; 304:81-90; PMID:15707576; http://dx.doi.org/10.1016/ j.yexcr.2004.11.011
130. Direkze NC, Forbes SJ, Brittan M, Hunt T, Jeffery R, Preston SL, et al. Multiple organ engraftment by bone-marrow-derived myofibroblasts and fibroblasts in bone-marrow-transplanted mice. Stem Cells 2003; 21:514-20; PMID:12968105; http://dx.doi.org/10.1634/stemcells.21-5-514
131. Fathke C, Wilson L, Hutter J, Kapoor V, Smith A, Hocking A, et al. Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair. Stem Cells 2004; 22:812-22; PMID:15342945; http://dx.doi.org/10.1634/ stemcells.22-5-812
132. Hashimoto N, Jin H, Liu T, Chensue SW, Phan SH. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 2004; 113:243-52; PMID:14722616
133. Hall B, Dembinski J, Sasser AK, Studeny M, Andreeff M, Marini F. Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles. Int J Hematol 2007; 86:8-16; PMID:17675260; http://dx.doi.org/10.1532/IJH97.06230
134. Studeny M, Marini FC, Dembinski JL, Zompetta C, Cabreira-Hansen M, Bekele BN, et al. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 2004; 96:1593-603; PMID:15523088; http://dx.doi.org/10.1093/jnci/djh299
135. Hung SC, Deng WP, Yang WK, Liu RS, Lee CC, Su TC, et al. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin Cancer Res 2005; 11:7749-56; PMID:16278396; http://dx.doi.org/10.1158/1078-0432.CCR-05-0876
136. Menon LG, Picinich S, Koneru R, Gao H, Lin SY, Koneru M, et al. Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Stem Cells 2007; 25:520-8; PMID:17053212; http://dx.doi.org/10.1634/stemcells.2006-0257
137. Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ, Andreeff M. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 2002; 62:3603-8; PMID:12097260
138. Komarova S, Kawakami Y, Stoff-Khalili MA, Curiel DT, Pereboeva L. Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses. Mol Cancer Ther 2006; 5:755-66; PMID:16546991; http://dx.doi.org/10.1158/1535-7163.MCT-05-0334
139. Khakoo AY, Pati S, Anderson SA, Reid W, Elshal MF, Rovira II, et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med 2006; 203:1235-47; PMID:16636132; http://dx.doi.org/10.1084/jem.20051921
140. Mishra PJ, Mishra PJ, Glod JW, Banerjee D. Mesenchymal stem cells: flip side of the coin. Cancer Res 2009; 69:1255-8; PMID:19208837; http://dx.doi.org/10.1158/0008-5472.CAN-08-3562
141. Opalenik SR, Davidson JM. Fibroblast differentiation of bone marrow-derived cells during wound repair. FASEB J 2005; 19:1561-3; PMID:16014399
142. Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, et al. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 2008; 68:4331-9; PMID:18519693; http://dx.doi.org/10.1158/ 0008-5472.CAN-08-0943
143. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007; 449:557-63; PMID:17914389; http://dx.doi.org/10.1038/nature06188
144. Barisic-Dujmovic T, Boban I, Clark SH. Fibroblasts/myofibroblasts that participate in cutaneous wound healing are not derived from circulating progenitor cells. J Cell Physiol 2010; 222:703-12; PMID:20020505
145. Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001; 19:180-92; PMID:11359943; http://dx.doi.org/10.1634/stemcells.19-3-180
146. Caplan AI. Why are MSCs therapeutic? New data: new insight. J Pathol 2009; 217:318-24; PMID:19023885; http://dx.doi.org/10.1002/path.2469
147. Hinz B. Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis. Curr Rheumatol Rep 2009; 11:120-6; PMID:19296884; http://dx.doi.org/ 10.1007/s11926-009-0017-1
148. Oft M, Heider KH, Beug H. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 1998; 8:1243-52; PMID:9822576; http://dx.doi.org/10.1016/S0960-9822(07)00533-7
149. Akhurst RJ, Derynck R. TGF-beta signaling in cancer - a double-edged sword. Trends Cell Biol 2001; 11:S44-51; PMID:11684442
150. ten Dijke P, Arthur HM. Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol 2007; 8:857-69; PMID:17895899; http://dx.doi.org/10.1038/nrm2262
151. Feng XH, Derynck R. Specificity and versatility in tgfbeta signaling through Smads. Annu Rev Cell Dev Biol 2005; 21:659-93; PMID:16212511; http://dx.doi.org/10.1146/annurev.cellbio.21.022404.142018
152. Wakefield LM, Stuelten C. Keeping order in the neighborhood: new roles for TGFbeta in maintaining epithelial homeostasis. Cancer Cell 2007; 12:293-5; PMID:17936552; http://dx.doi.org/10.1016/j.ccr.2007.10.002
153. Bierie B, Moses HL. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 2006; 6:506-20; PMID:16794634; http://dx.doi.org/10.1038/nrc1926
154. Pardali K, Moustakas A. Actions of TGF-beta as tumor suppressor and
155. Ikushima H, Miyazono K. TGFbeta signalling: a complex web in cancer progression. Nat Rev Cancer 2010; 10:415-24; PMID:20495575; http://dx.doi.org/ 10.1038/nrc2853
156. Azuma H, Ehata S, Miyazaki H, Watabe T, Maruyama O, Imamura T, et al. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells. J Natl Cancer Inst 2005; 97:1734-46; PMID:16333029; http://dx.doi.org/10. 1093/jnci/dji399
157. Padua D, Zhang XH, Wang Q, Nadal C, Gerald WL, Gomis RR, et al. TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 2008; 133:66-77; PMID:18394990; http://dx.doi.org/10.1016/j.cell.2008.01. 046
158. Guasch G, Schober M, Pasolli HA, Conn EB, Polak L, Fuchs E. Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia. Cancer Cell 2007; 12:313-27; PMID:17936557; http://dx.doi.org/10.1016/j.ccr.2007.08.020
159. Meulmeester E, Ten Dijke P. The dynamic roles of TGF-β in cancer. J Pathol 2011; 223:205-18; PMID:20957627; http://dx.doi.org/10.1002/path.2785
160. Desmoulière A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993; 122:103-11; PMID:8314838; http://dx.doi.org/10.1083/jcb.122.1.103
161. Zhang HY, Phan SH. Inhibition of myofibroblast apoptosis by transforming growth factor beta(1). Am J Respir Cell Mol Biol 1999; 21:658-65; PMID:10572062
162. Taipale J, Saharinen J, Keski-Oja J. Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion. Adv Cancer Res 1998; 75:87-134; PMID:9709808; http://dx.doi.org/10.1016/S0065- 230X(08)60740-X
163. Ruiz-Ortega M, Rodríguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J. TGF-beta signaling in vascular fibrosis. Cardiovasc Res 2007; 74:196-206; PMID:17376414; http://dx.doi.org/10.1016/j.cardiores.2007.02.008
164. Grainger DJ. TGF-beta and atherosclerosis in man. Cardiovasc Res 2007; 74:213-22; PMID:17382916; http://dx.doi.org/10.1016/j.cardiores.2007.02.022
165. Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J 2004; 18:816-27; PMID:15117886; http://dx.doi.org/10.1096/fj.03-1273rev
166. Meran S, Thomas D, Stephens P, Martin J, Bowen T, Phillips A, et al. Involvement of hyaluronan in regulation of fibroblast phenotype. J Biol Chem 2007; 282:25687-97; PMID:17611197; http://dx.doi.org/10.1074/jbc.M700773200
167. Webber J, Meran S, Steadman R, Phillips A. Hyaluronan orchestrates transforming growth factor-beta1-dependent maintenance of myofibroblast phenotype. J Biol Chem 2009; 284:9083-92; PMID:19193641; http://dx.doi.org/10. 1074/jbc.M806989200
168. Joshi A, Cao D. TGF-beta signaling, tumor microenvironment and tumor progression: the butterfly effect. Front Biosci 2010; 15:180-94; PMID:20036814; http://dx.doi.org/10.2741/3614
169. Kojima Y, Acar A, Eaton EN, Mellody KT, Scheel C, Ben-Porath I, et al. Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc Natl Acad Sci U S A 2010; 107:20009-14; PMID:21041659; http://dx.doi.org/10.1073/pnas. 1013805107
170. Hawinkels LJ, Ten Dijke P. Exploring anti-TGF-βtherapies in cancer and fibrosis. Growth Factors 2011; 29:140-52; PMID:21718111; http://dx.doi.org/10.3109/08977194.2011.595411
171. Varga J, Pasche B. Transforming growth factor beta as a therapeutic target in systemic sclerosis. Nat Rev Rheumatol 2009; 5:200-6; PMID:19337284; http://dx.doi.org/10.1038/nrrheum.2009.26
172. Hinz B, Gabbiani G. Fibrosis: recent advances in myofibroblast biology and new therapeutic perspectives. F1000 Biol Rep 2010; 2:78; PMID:21170369; http://dx.doi.org/10.3410/B2-78
173. Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFbeta activation. J Cell Sci 2003; 116:217-24; PMID:12482908; http://dx.doi.org/10. 1242/jcs.00229
174. Hyytiäinen M, Penttinen C, Keski-Oja J. Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. Crit Rev Clin Lab Sci 2004; 41:233-64; PMID:15307633; http://dx.doi.org/10.1080/ 10408360490460933
175. Jenkins G. The role of proteases in transforming growth factor-beta activation. Int J Biochem Cell Biol 2008; 40:1068-78; PMID:18243766; http://dx.doi.org/10.1016/j.biocel.2007.11.026
176. Wipff PJ, Hinz B. Integrins and the activation of latent transforming growth factor beta1 - an intimate relationship. Eur J Cell Biol 2008; 87:601-15; PMID:18342983; http://dx.doi.org/10.1016/j.ejcb.2008.01.012
177. Derynck R, Jarrett JA, Chen EY, Goeddel DV. The murine transforming growth factor-beta precursor. J Biol Chem 1986; 261:4377-9; PMID:3007454
178. Worthington JJ, Klementowicz JE, Travis MA. TGFβ: a sleeping giant awoken by integrins. Trends Biochem Sci 2011; 36:47-54; PMID:20870411; http://dx.doi.org/10.1016/j.tibs.2010.08.002
179. Shi M, Zhu J, Wang R, Chen X, Mi L, Walz T, et al. Latent TGF-β structure and activation. Nature 2011; 474:343-9; PMID:21677751; http://dx.doi.org/10.1038/nature10152
180. Nishimura SL. Integrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders. Am J Pathol 2009; 175:1362-70; PMID:19729474; http://dx.doi.org/10.2353/ajpath.2009.090393
181. Sheppard D. Integrin-mediated activation of latent transforming growth factor beta. Cancer Metastasis Rev 2005; 24:395-402; PMID:16258727; http://dx.doi.org/10.1007/s10555-005-5131-6
182. Mu D, Cambier S, Fjellbirkeland L, Baron JL, Munger JS, Kawakatsu H, et al. The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1. J Cell Biol 2002; 157:493-507; PMID:11970960; http://dx.doi.org/10.1083/jcb.200109100
183. Wipff PJ, Rifkin DB, Meister JJ, Hinz B. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol 2007; 179:1311-23; PMID:18086923; http://dx.doi.org/10.1083/jcb.200704042
184. Buscemi L, Ramonet D, Klingberg F, Formey A, Smith-Clerc J, Meister JJ, et al. The single-molecule mechanics of the latent TGF-β1 complex. Curr Biol 2011; 21:2046-54; PMID:22169532; http://dx.doi.org/10.1016/j.cub.2011.11. 037
185. Zhou Y, Hagood JS, Lu B, Merryman WD, Murphy-Ullrich JE. Thy-1-integrin alphav beta5 interactions inhibit lung fibroblast contraction-induced latent transforming growth factor-beta1 activation and myofibroblast differentiation. J Biol Chem 2010; 285:22382-93; PMID:20463011; http://dx.doi.org/10.1074/jbc. M110.126227
186. Maeda T, Sakabe T, Sunaga A, Sakai K, Rivera AL, Keene DR, et al. Conversion of mechanical force into TGF-β-mediated biochemical signals. Curr Biol 2011; 21:933-41; PMID:21600772; http://dx.doi.org/10.1016/j.cub.2011. 04.007
187. Ahamed J, Burg N, Yoshinaga K, Janczak CA, Rifkin DB, Coller BS. In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-beta1. Blood 2008; 112:3650-60; PMID:18544680; http://dx.doi.org/10. 1182/blood-2008-04-151753
188. Giacomini MM, Travis MA, Kudo M, Sheppard D. Epithelial cells utilize cortical actin/myosin to activate latent TGF-β through integrin α(v)β(6)-dependent physical force. Exp Cell Res 2012; 318:716-22; PMID:22309779; http://dx.doi.org/10.1016/j.yexcr.2012.01.020
189. Aluwihare P, Munger JS. What the lung has taught us about latent TGF-beta activation. Am J Respir Cell Mol Biol 2008; 39:499-502; PMID:18927350; http://dx.doi.org/10.1165/rcmb.2008-0003ED
190. Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999; 96:319-28; PMID:10025398; http://dx.doi.org/10.1016/S0092-8674(00)80545-0
191. Horan GS, Wood S, Ona V, Li DJ, Lukashev ME, Weinreb PH, et al. Partial inhibition of integrin alpha (v)beta6 prevents pulmonary fibrosis without exacerbating inflammation. Am J Respir Crit Care Med 2008; 177:56-65; PMID:17916809; http://dx.doi.org/10.1164/rccm.200706-805OC
192. Bates RC, Bellovin DI, Brown C, Maynard E, Wu B, Kawakatsu H, et al. Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest 2005; 115:339-47; PMID:15668738
193. Ramos DM, Dang D, Sadler S. The role of the integrin alpha v beta6 in regulating the epithelial to mesenchymal transition in oral cancer. Anticancer Res 2009; 29:125-30; PMID:19331141
194. Weis SM, Cheresh DA. Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med 2011; 17:1359-70; PMID:22064426; http://dx.doi.org/10.1038/nm.2537
195. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 2005; 8:241-54; PMID:16169468; http://dx.doi.org/10.1016/j.ccr.2005.08.010
196. Kumar S, Weaver VM. Mechanics, malignancy, and metastasis: the force journey of a tumor cell. Cancer Metastasis Rev 2009; 28:113-27; PMID:19153673; http://dx.doi.org/10.1007/s10555-008-9173-4
197. Beacham DA, Cukierman E. Stromagenesis: the changing face of fibroblastic microenvironments during tumor progression. Semin Cancer Biol 2005; 15:329-41; PMID:15970443; http://dx.doi.org/10.1016/j.semcancer.2005.05.003
198. Andersen ES, Christensen PB, Weis N. Transient elastography for liver fibrosis diagnosis. Eur J Intern Med 2009; 20:339-42; PMID:19524169; http://dx.doi.org/10.1016/j.ejim.2008.09.020
199. DuFort CC, Paszek MJ, Weaver VM. Balancing forces: architectural control of mechanotransduction. Nat Rev Mol Cell Biol 2011; 12:308-19; PMID:21508987; http://dx.doi.org/10.1038/nrm3112
200. Khaled W, Reichling S, Bruhns OT, Ermert H. Ultrasonic strain imaging and reconstructive elastography for biological tissue. Ultrasonics 2006; 44(Suppl 1):e199-202; PMID:16857230; http://dx.doi.org/10.1016/j.ultras.2006.06.007
201. Glaser KJ, Felmlee JP, Manduca A, Kannan Mariappan Y, Ehman RL. Stiffness-weighted magnetic resonance imaging. Magn Reson Med 2006; 55:59-67; PMID:16342158; http://dx.doi.org/10.1002/mrm.20748
202. Garra BS. Imaging and estimation of tissue elasticity by ultrasound. Ultrasound Q 2007; 23:255-68; PMID:18090836; http://dx.doi.org/10.1097/ruq. 0b013e31815b7ed6
203. Santhanam AN, Baker AR, Hegamyer G, Kirschmann DA, Colburn NH. Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion. Oncogene 2010; 29:3921-32; PMID:20498644; http://dx.doi.org/10.1038/ onc.2010.158
204. Georges PC, Hui JJ, Gombos Z, McCormick ME, Wang AY, Uemura M, et al. Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. Am J Physiol Gastrointest Liver Physiol 2007; 293:G1147-54; PMID:17932231; http://dx.doi.org/10.1152/ajpgi.00032.2007
205. Barker HE, Chang J, Cox TR, Lang G, Bird D, Nicolau M, et al. LOXL2-mediated matrix remodeling in metastasis and mammary gland involution. Cancer Res 2011; 71:1561-72; PMID:21233336; http://dx.doi.org/10.1158/0008-5472. CAN-10-2868
206. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009; 139:891-906; PMID:19931152; http://dx.doi.org/10.1016/j.cell.2009.10.027
207. Heldin CH, Rubin K, Pietras K, Ostman A. High interstitial fluid pressure - an obstacle in cancer therapy. Nat Rev Cancer 2004; 4:806-13; PMID:15510161; http://dx.doi.org/10.1038/nrc1456
208. Swartz MA, Fleury ME. Interstitial flow and its effects in soft tissues. Annu Rev Biomed Eng 2007; 9:229-56; PMID:17459001; http://dx.doi.org/10.1146/ annurev.bioeng.9.060906.151850
209. Ng CP, Hinz B, Swartz MA. Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro. J Cell Sci 2005; 118:4731-9; PMID:16188933; http://dx.doi.org/10.1242/jcs.02605
210. Shieh AC, Rozansky HA, Hinz B, Swartz MA. Tumor cell invasion is promoted by interstitial flow-induced matrix priming by stromal fibroblasts. Cancer Res 2011; 71:790-800; PMID:21245098; http://dx.doi.org/10.1158/0008-5472.CAN-10-1513
211. Butcher DT, Alliston T, Weaver VM. A tense situation: forcing tumour progression. Nat Rev Cancer 2009; 9:108-22; PMID:19165226; http://dx.doi.org/10. 1038/nrc2544
212. Yu H, Mouw JK, Weaver VM. Forcing form and function: biomechanical regulation of tumor evolution. Trends Cell Biol 2011; 21:47-56; PMID:20870407; http://dx.doi.org/10.1016/j.tcb.2010.08.015
213. Goffin JM, Pittet P, Csucs G, Lussi JW, Meister JJ, Hinz B. Focal adhesion size controls tension-dependent recruitment of alpha-smooth muscle actin to stress fibers. J Cell Biol 2006; 172:259-68; PMID:16401722; http://dx.doi.org/10.1083/jcb.200506179
214. Liu F, Mih JD, Shea BS, Kho AT, Sharif AS, Tager AM, et al. Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression. J Cell Biol 2010; 190:693-706; PMID:20733059; http://dx.doi.org/10.1083/jcb. 201004082
215. Olsen AL, Bloomer SA, Chan EP, Gaça MD, Georges PC, Sackey B, et al. Hepatic stellate cells require a stiff environment for myofibroblastic differentiation. Am J Physiol Gastrointest Liver Physiol 2011; 301:G110-8; PMID:21527725; http://dx.doi.org/10.1152/ajpgi.00412.2010
216. Bissell MJ, Hines WC. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 2011; 17:320-9; PMID:21383745; http://dx.doi.org/10.1038/nm.2328
217. Assoian RK, Klein EA. Growth control by intracellular tension and extracellular stiffness. Trends Cell Biol 2008; 18:347-52; PMID:18514521; http://dx.doi.org/10.1016/j.tcb.2008.05.002
218. Chan MW, Hinz B, McCulloch CA. Mechanical induction of gene expression in connective tissue cells. Methods Cell Biol 2010; 98:178-205; PMID:20816235; http://dx.doi.org/10.1016/S0091-679X(10)98008-4
219. Buxboim A, Ivanovska IL, Discher DE. Matrix elasticity, cytoskeletal forces and physics of the nucleus: how deeply do cells 'feel' outside and in? J Cell Sci 2010; 123:297-308; PMID:20130138; http://dx.doi.org/10.1242/jcs.041186
220. Grinnell F, Petroll WM. Cell motility and mechanics in three-dimensional collagen matrices. Annu Rev Cell Dev Biol 2010; 26:335-61; PMID:19575667; http://dx.doi.org/10.1146/annurev.cellbio.042308.113318
221. Janmey PA, Winer JP, Murray ME, Wen Q. The hard life of soft cells. Cell Motil Cytoskeleton 2009; 66:597-605; PMID:19479819; http://dx.doi.org/10.1002/ cm.20382
222. Swartz MA, Lund AW. Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity. Nat Rev Cancer 2012; 12:210-9; PMID:22362216; http://dx.doi.org/10.1038/nrc3186
223. Yeung T, Georges PC, Flanagan LA, Marg B, Ortiz M, Funaki M, et al. Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion. Cell Motil Cytoskeleton 2005; 60:24-34; PMID:15573414; http://dx.doi.org/10.1002/cm.20041
224. Grinnell F. Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol 1994; 124:401-4; PMID:8106541; http://dx.doi.org/10.1083/jcb.124.4.401
225. Arora PD, Narani N, McCulloch CA. The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. Am J Pathol 1999; 154:871-82; PMID:10079265; http://dx.doi.org/10.1016/S0002-9440(10)65334-5
226. Hinz B. Masters and servants of the force: the role of matrix adhesions in myofibroblast force perception and transmission. Eur J Cell Biol 2006; 85:175-81; PMID:16546559; http://dx.doi.org/10.1016/j.ejcb.2005.09.004
227. Junker JP, Kratz C, Tollbäck A, Kratz G. Mechanical tension stimulates the transdifferentiation of fibroblasts into myofibroblasts in human burn scars. Burns 2008; 34:942-6; PMID:18472340; http://dx.doi.org/10.1016/j. burns.2008.01.010
228. Grinnell F, Zhu M, Carlson MA, Abrams JM. Release of mechanical tension triggers apoptosis of human fibroblasts in a model of regressing granulation tissue. Exp Cell Res 1999; 248:608-19; PMID:10222153; http://dx.doi.org/10.1006/ excr.1999.4440
229. Carlson MA, Longaker MT, Thompson JS. Wound splinting regulates granulation tissue survival. J Surg Res 2003; 110:304-9; PMID:12697415; http://dx.doi.org/10.1016/S0022-4804(02)00098-7
230. Aarabi S, Bhatt KA, Shi Y, Paterno J, Chang EI, Loh SA, et al. Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis. FASEB J 2007; 21:3250-61; PMID:17504973; http://dx.doi.org/10.1096/ fj.07-8218com
231. Räsänen K, Vaheri A. Activation of fibroblasts in cancer stroma. Exp Cell Res 2010; 316:2713-22; PMID:20451516; http://dx.doi.org/10. 1016/j.yexcr.2010.04.032
232. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009; 9:239-52; PMID:19279573; http://dx.doi.org/10.1038/nrc2618
233. Lu P, Takai K, Weaver VM, Werb Z. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol 2011; 3:a005058; PMID:21917992; http://dx.doi.org/10.1101/cshperspect.a005058
234. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007; 356:227-36; PMID:17229950; http://dx.doi.org/10.1056/NEJMoa062790
235. Wolfe JN. Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 1976; 37:2486-92; PMID:1260729; http://dx.doi.org/ 10.1002/1097-0142(197605)37:5〈2486::AID-CNCR2820370542〉3.0.CO;2-8
236. Winer JP, Janmey PA, McCormick ME, Funaki M. Bone marrow-derived human mesenchymal stem cells become quiescent on soft substrates but remain responsive to chemical or mechanical stimuli. Tissue Eng Part A 2009; 15:147-54; PMID:18673086; http://dx.doi.org/10.1089/ten.tea.2007.0388
237. Klein EA, Yin L, Kothapalli D, Castagnino P, Byfield FJ, Xu T, et al. Cell-cycle control by physiological matrix elasticity and in vivo tissue stiffening. Curr Biol 2009; 19:1511-8; PMID:19765988; http://dx.doi.org/10.1016/ j.cub.2009.07.069
238. Gritsenko PG, Ilina O, Friedl P. Interstitial guidance of cancer invasion. J Pathol 2012; 226:185-99; PMID:22006671; http://dx.doi.org/10.1002/ path.3031
239. Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall JF, Harrington K, et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 2007; 9:1392-400; PMID:18037882; http://dx.doi.org/10.1038/ncb1658
240. Condeelis J, Segall JE. Intravital imaging of cell movement in tumours. Nat Rev Cancer 2003; 3:921-30; PMID:14737122; http://dx.doi.org/10.1038/nrc1231
241. Ilina O, Bakker GJ, Vasaturo A, Hofmann RM, Friedl P. Two-photon laser-generated microtracks in 3D collagen lattices: principles of MMP-dependent and -independent collective cancer cell invasion. Phys Biol 2011; 8:015010; PMID:21301056; http://dx.doi.org/10.1088/1478-3975/8/1/015010
242. Friedl P, Alexander S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 2011; 147:992-1009; PMID:22118458; http://dx.doi.org/10.1016/j.cell.2011.11.016
243. Conklin MW, Eickhoff JC, Riching KM, Pehlke CA, Eliceiri KW, Provenzano PP, et al. Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am J Pathol 2011; 178:1221-32; PMID:21356373; http://dx.doi.org/10.1016/j.ajpath.2010.11.076
244. Liu K, He X, Lei XZ, Zhao LS, Tang H, Liu L, et al. Pathomorphological study on location and distribution of Kupffer cells in hepatocellular carcinoma. World J Gastroenterol 2003; 9:1946-9; PMID:12970881
245. Faouzi S, Le Bail B, Neaud V, Boussarie L, Saric J, Bioulac-Sage P, et al. Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma: an in vivo and in vitro study. J Hepatol 1999; 30:275-84; PMID:10068108; http://dx.doi.org/10.1016/S0168-8278(99)80074-9
246. Dubuisson L, Lepreux S, Bioulac-Sage P, Balabaud C, Costa AM, Rosenbaum J, et al. Expression and cellular localization of fibrillin-1 in normal and pathological human liver. J Hepatol 2001; 34:514-22; PMID:11394650; http://dx.doi.org/10.1016/S0168-8278(00)00048-9
247. Le Bail B, Faouzi S, Boussarie L, Guirouilh J, Blanc JF, Carles J, et al. Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma. J Pathol 1999; 189:46-52; PMID:10451487; http://dx.doi.org/10.1002/(SICI)1096- 9896(199909)189:1〈46::AID-PATH392〉3.0.CO;2-X
248. Monvoisin A, Neaud V, De Lédinghen V, Dubuisson L, Balabaud C, Bioulac-Sage P, et al. Direct evidence that hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells is mediated by urokinase. J Hepatol 1999; 30:511-8; PMID:10190737; http://dx.doi.org/10.1016/S0168-8278(99)80113-5
249. Dubuisson L, Monvoisin A, Nielsen BS, Le Bail B, Bioulac-Sage P, Rosenbaum J. Expression and cellular localization of the urokinase-type plasminogen activator and its receptor in human hepatocellular carcinoma. J Pathol 2000; 190:190-5; PMID:10657018; http://dx.doi.org/10.1002/(SICI)1096- 9896(200002)190:2〈190::AID-PATH511〉3.0.CO;2-H
250. Monvoisin A, Bisson C, Si-Tayeb K, Balabaud C, Desmoulière A, Rosenbaum J. Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells. Int J Cancer 2002; 97:157-62; PMID:11774258; http://dx.doi.org/10.1002/ijc.1595
251. Leyland H, Gentry J, Arthur MJ, Benyon RC. The plasminogen-activating system in hepatic stellate cells. Hepatology 1996; 24:1172-8; PMID:8903394; http://dx.doi.org/10.1002/hep.510240532
252. Neaud V, Faouzi S, Guirouilh J, Le Bail B, Balabaud C, Bioulac-Sage P, et al. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor. Hepatology 1997; 26:1458-66; PMID:9397985; http://dx.doi.org/10.1002/hep.510260612
253. Neaud V, Hisaka T, Monvoisin A, Bedin C, Balabaud C, Foster DC, et al. Paradoxical pro-invasive effect of the serine proteinase inhibitor tissue factor pathway inhibitor-2 on human hepatocellular carcinoma cells. J Biol Chem 2000; 275:35565-9; PMID:10954721; http://dx.doi.org/10.1074/jbc.M006101200
254. Yamamoto H, Itoh F, Adachi Y, Sakamoto H, Adachi M, Hinoda Y, et al. Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma. Gastroenterology 1997; 112:1290-6; PMID:9098015; http://dx.doi.org/10.1016/S0016-5085(97)70143-4
255. Terada T, Makimoto K, Terayama N, Suzuki Y, Nakanuma Y. Alpha-smooth muscle actin-positive stromal cells in cholangiocarcinomas, hepatocellular carcinomas and metastatic liver carcinomas. J Hepatol 1996; 24:706-12; PMID:8835746; http://dx.doi.org/10.1016/S0168-8278(96)80267-4
256. Okamura N, Yoshida M, Shibuya A, Sugiura H, Okayasu I, Ohbu M. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas. Pathol Int 2005; 55:724-31; PMID:16271085; http://dx.doi.org/10.1111/j.1440- 1827.2005.01891.x
257. Terada T, Okada Y, Nakanuma Y. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors. Hepatology 1996; 23:1341-4; PMID:8675149; http://dx.doi.org/10.1002/hep.510230608
258. Darby IA, Vuillier-Devillers K, Pinault E, Sarrazy V, Lepreux S, Balabaud C, et al. Proteomic analysis of differentially expressed proteins in peripheral cholangiocarcinoma. Cancer Microenviron 2010; 4:73-91; PMID:21505563; http://dx.doi.org/10.1007/s12307-010-0047-2
259. Li Z, Zhao J, Du Y, Park HR, Sun SY, Bernal-Mizrachi L, et al. Down-regulation of 14-3-3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation. Proc Natl Acad Sci U S A 2008; 105:162-7; PMID:18162532; http://dx.doi.org/10.1073/pnas.0710905105
260. Tilman G, Mattiussi M, Brasseur F, van Baren N, Decottignies A. Human periostin gene expression in normal tissues, tumors and melanoma: evidences for periostin production by both stromal and melanoma cells. Mol Cancer 2007; 6:80; PMID:18086302; http://dx.doi.org/10.1186/1476-4598-6-80
261. Utispan K, Thuwajit P, Abiko Y, Charngkaew K, Paupairoj A, Chau-in S, et al. Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker. Mol Cancer 2010; 9:13; PMID:20096135; http://dx.doi.org/10. 1186/1476-4598-9-13
262. Kanno A, Satoh K, Masamune A, Hirota M, Kimura K, Umino J, et al. Periostin, secreted from stromal cells, has biphasic effect on cell migration and correlates with the epithelial to mesenchymal transition of human pancreatic cancer cells. Int J Cancer 2008; 122:2707-18; PMID:18381746; http://dx.doi.org/10.1002/ijc.23332
263. Fujimoto K, Kawaguchi T, Nakashima O, Ono J, Ohta S, Kawaguchi A, et al. Periostin, a matrix protein, has potential as a novel serodiagnostic marker for cholangiocarcinoma. Oncol Rep 2011; 25:1211-6; PMID:21347516; http://dx.doi.org/10.3892/or.2011.1194
264. Guyot C, Lepreux S, Combe C, Doudnikoff E, Bioulac-Sage P, Balabaud C, et al. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved. Int J Biochem Cell Biol 2006; 38:135-51; PMID:16257564
265. Forbes SJ, Parola M. Liver fibrogenic cells. Best Pract Res Clin Gastroenterol 2011; 25:207-17; PMID:21497739; http://dx.doi.org/10.1016/j.bpg. 2011.02.006
266. Guyot C, Combe C, Balabaud C, Bioulac-Sage P, Desmoulière A. Fibrogenic cell fate during fibrotic tissue remodelling observed in rat and human cultured liver slices. J Hepatol 2007; 46:142-50; PMID:17069927; http://dx.doi.org/10.1016/j.jhep.2006.08.013
267. Guyot C, Lepreux S, Combe C, Sarrazy V, Billet F, Balabaud C, et al. Fibrogenic cell phenotype modifications during remodelling of normal and pathological human liver in cultured slices. Liver Int 2010; 30:1529-40; PMID:20846345; http://dx.doi.org/10.1111/j.1478-3231.2010.02342.x
268. Bosselut N, Housset C, Marcelo P, Rey C, Burmester T, Vinh J, et al. Distinct proteomic features of two fibrogenic liver cell populations: hepatic stellate cells and portal myofibroblasts. Proteomics 2010; 10:1017-28; PMID:20049859
269. Theise N, Nakashima O, Park Y, Nakanuma Y. Combined hepatocellular- cholangiocarcinoma. In: Bosman FT CF, Hruban RH, Theise ND, ed. WHO classification of tumors of the digestive system. Lyon (France): IARC Press, 2010:225-7.
270. Seok JY, Na DC, Woo HG, Roncalli M, Kwon SM, Yoo JE, et al. A fibrous stromal component in hepato-cellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and EMT. Hepatology 2012; 55:1776-86; PMID:22234953; http://dx.doi.org/10.1002/hep.25570
271. Greenbaum LE, Wells RG. The role of stem cells in liver repair and fibrosis. Int J Biochem Cell Biol 2011; 43:222-9; PMID:19914396; http://dx.doi.org/10.1016/j.biocel.2009.11.006
272. Fujimiya T, Liu J, Kojima H, Shirafuji S, Kimura H, Fujimiya M. Pathological roles of bone marrow-derived stellate cells in a mouse model of alcohol-induced fatty liver. Am J Physiol Gastrointest Liver Physiol 2009; 297:G451-60; PMID:19608736; http://dx.doi.org/10.1152/ajpgi.00055.2009
273. Higashiyama R, Moro T, Nakao S, Mikami K, Fukumitsu H, Ueda Y, et al. Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice. Gastroenterology 2009; 137:1459-66, e1; PMID:19596008; http://dx.doi.org/10.1053/j.gastro.2009.07.006
274. Chu AS, Diaz R, Hui JJ, Yanger K, Zong Y, Alpini G, et al. Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis. Hepatology 2011; 53:1685-95; PMID:21520179; http://dx.doi.org/10.1002/hep.24206
275. Popov Y, Schuppan D. Epithelial-to-mesenchymal transition in liver fibrosis: dead or alive? Gastroenterology 2010; 139:722-5; PMID:20682361; http://dx.doi.org/10.1053/j.gastro.2010.07.015
276. Taras D, Blanc JF, Rullier A, Dugot-Senant N, Laurendeau I, Bièche I, et al. Halofuginone suppresses the lung metastasis of chemically induced hepatocellular carcinoma in rats through MMP inhibition. Neoplasia 2006; 8:312-8; PMID:16756723; http://dx.doi.org/10.1593/neo.05796
277. Jan YY, Yeh TS, Yeh JN, Yang HR, Chen MF. Expression of epidermal growth factor receptor, apomucins, matrix metalloproteinases, and p53 in rat and human cholangiocarcinoma: appraisal of an animal model of cholangiocarcinoma. Ann Surg 2004; 240:89-94; PMID:15213623; http://dx.doi.org/10.1097/01.sla.0000129492. 95311.f2
278. Yeh CN, Maitra A, Lee KF, Jan YY, Chen MF. Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multistage progression of human cholangiocarcinoma. Carcinogenesis 2004; 25:631-6; PMID:14656942; http://dx.doi.org/10.1093/carcin/bgh037
279. Gao Q, Wang XY, Qiu SJ, Zhou J, Shi YH, Zhang BH, et al. Tumor stroma reaction-related gene signature predicts clinical outcome in human hepatocellular carcinoma. Cancer Sci 2011; 102:1522-31; PMID:21564420; http://dx.doi.org/10.1111/j.1349-7006.2011.01981.x
280. Hinz B, Gabbiani G, Chaponnier C. The NH2-terminal peptide of alpha-smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo. J Cell Biol 2002; 157:657-63; PMID:11994316; http://dx.doi.org/10.1083/jcb.200201049
281. Hinz B, Gabbiani G. Cell-matrix and cell-cell contacts of myofibroblasts: role in connective tissue remodeling. Thromb Haemost 2003; 90:993-1002; PMID:14652629
282. Uchio K, Graham M, Dean NM, Rosenbaum J, Desmoulière A. Down-regulation of connective tissue growth factor and type I collagen mRNA expression by connective tissue growth factor antisense oligonucleotide during experimental liver fibrosis. Wound Repair Regen 2004; 12:60-6; PMID:14974966; http://dx.doi.org/10.1111/j.1067-1927.2004.012112.x-1